Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Melagatran

A direct thrombin inhibitor, blocking the key enzyme of blood clotting: it is the active form of ximelagatran, an oral anticoagulant marketed in some European countries in the mid-2000s and withdrawn in 2006. This family brings together the active ingredient.

Did you know?It was designed starting from the crystal structure of thrombin bound to an inhibitor; since it was poorly absorbed by mouth, it was turned into a 'double prodrug', ximelagatran, the first oral direct thrombin inhibitor to enter clinical trials.

MelagatranGo to the active ingredient →
MelagatranActive ingredientMelagatranCat. No. P-M036-001CAS 159776-70-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.